216 related articles for article (PubMed ID: 25243648)
21. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
Godfrey EL; Malik TH; Lai JC; Mindikoglu AL; Galván NTN; Cotton RT; O'Mahony CA; Goss JA; Rana A
Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
[TBL] [Abstract][Full Text] [Related]
22. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
[TBL] [Abstract][Full Text] [Related]
23. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.
Shaffer AA; Thomas AG; Bowring MG; Van Pilsum Rasmussen SE; Cash A; Kucirka LM; Alqahtani SA; Gurakar A; Sulkowski MS; Cameron AM; Segev DL; Durand CM
Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258
[TBL] [Abstract][Full Text] [Related]
24. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
Tanemura A; Mizuno S; Kato H; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
[TBL] [Abstract][Full Text] [Related]
25. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP
Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
[TBL] [Abstract][Full Text] [Related]
26. Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over.
Caso-Maestro O; Jiménez-Romero C; Justo-Alonso I; Calvo-Pulido J; Lora-Pablos D; Marcacuzco-Quinto A; Cambra-Molero F; García-Sesma A; Pérez-Flecha M; Muñoz-Arce C; Loinaz-Segurola C; Manrique-Municio A
World J Gastroenterol; 2018 Dec; 24(47):5391-5402. PubMed ID: 30598583
[TBL] [Abstract][Full Text] [Related]
27. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.
Schaubel DE; Sima CS; Goodrich NP; Feng S; Merion RM
Am J Transplant; 2008 Feb; 8(2):419-25. PubMed ID: 18190658
[TBL] [Abstract][Full Text] [Related]
28. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
29. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
30. Risk Assessment in High- and Low-MELD Liver Transplantation.
Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
[TBL] [Abstract][Full Text] [Related]
31. Effects of graft quality on non-urgent liver retransplantation survival: should we avoid high-risk donors?
Marti J; Fuster J; Navasa M; Ferrer J; Rimola A; Pelegrina A; Fondevila C; Garcia-Valdecasas JC
World J Surg; 2012 Dec; 36(12):2914-22. PubMed ID: 22968536
[TBL] [Abstract][Full Text] [Related]
32. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
[TBL] [Abstract][Full Text] [Related]
33. Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.
Mazur RD; Goldberg DS
Liver Transpl; 2019 Dec; 25(12):1800-1810. PubMed ID: 31539195
[TBL] [Abstract][Full Text] [Related]
34. Improved posttransplant mortality after share 35 for liver transplantation.
Kwong AJ; Goel A; Mannalithara A; Kim WR
Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
[TBL] [Abstract][Full Text] [Related]
35. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
36. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
[TBL] [Abstract][Full Text] [Related]
37. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.
Bekki Y; Crismale JF; Myers B; Schiano TD; Florman S
Transplantation; 2022 Sep; 106(9):1787-1798. PubMed ID: 35507448
[TBL] [Abstract][Full Text] [Related]
38. The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation.
Brüggenwirth IMA; Werner MJM; Adam R; Polak WG; Karam V; Heneghan MA; Mehrabi A; Klempnauer JL; Paul A; Mirza DF; Pratschke J; Salizzoni M; Cherqui D; Allison M; Soubrane O; Staffa SJ; Zurakowski D; Porte RJ; de Meijer VE;
Transpl Int; 2021 Oct; 34(10):1928-1937. PubMed ID: 34160850
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
[TBL] [Abstract][Full Text] [Related]
40. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.
Cholankeril G; Li AA; Dennis BB; Gadiparthi C; Kim D; Toll AE; Maliakkal BJ; Satapathy SK; Nair S; Ahmed A
Sci Rep; 2019 Jun; 9(1):8312. PubMed ID: 31165776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
